237 results on '"Coutance G"'
Search Results
2. Prophylaxie de la Pneumocystose et de la Toxoplasmose chez les transplantés cardiaques par une faible dose de triméthoprime-sulfaméthoxazole 20/100 mg. PAPTO-LOCO study.
3. Impact of Early Graft Dysfunction on Conditional 1-Year Post-Transplant Survival: A French National Cohort Study
4. Second Opinion Heart Transplantation After a Previous Contra-Indication in Another Center is Associated with Favorable Post-Transplant Outcomes. A Single High-Volume Center Experience
5. Fifteen Years Experience of Veno-Arterial Extracorporeal Membrane Oxygenation for Primary Graft Dysfunction After Heart Transplantation
6. Short-Term Immuno-Molecular Landscape in 10-Gene Edited Pig-to-Human Heart Xenografts
7. Banff Human Organ Transplant consensus gene panel for detecting antibody mediated rejection in heart allograft biopsies
8. Importance of transplant era on post-heart transplant predictive models: A UNOS cohort analysis
9. Intermediate-term outcomes of complement inhibition for prevention of antibody-mediated rejection in immunologically high-risk heart allograft recipients
10. Validation of the clinical utility of MicroRNA as non-invasive biomarkers of cardiac allograft rejection monitoring: A prospective longitudinal multicenter study
11. Incidence and determinants of non-radial vascular approach for coronary angiography among heart transplant recipients
12. PB0354 Use of Intraoperative Heparin in Combination with Cangrelor in Patients with Acute Heparin-Induced Thrombocytopenia Undergoing Cardiopulmonary Bypass for Heart Transplantation: A Case Series
13. (132) Molecular Diagnostic Classification of Heart Allograft Rejection Based on the Targeted Banff Human Organ Transplant Gene Expression Panel
14. (999) Validation of the Clinical Utility of MicroRNA as Non-Invasive Biomarkers of Cardiac Allograft Rejection Monitoring: A Prospective Longitudinal Multicenter Study
15. (358) Banff Human Organ Transplant Consensus Gene Panel for Detecting Antibody Mediated Rejection in Heart Allograft Biopsies
16. (103) Homozygosity at Multiple HLA Loci Increases the Risk of Sensitization but Decreases the Risk of Rejection
17. Recipient/donor profile evolution: 15 years analysis on 1152 isolated heart transplant recipients.
18. Application of the new cardiac allograft allocation scheme in clinical practice. Insights from a high-volume heart transplantation center
19. Impact of the 2018 French allocation scheme on the profile of heart transplantation candidates, recipients and donors: Insights from a high-volume center
20. Prognosis value of Forrester's classification in advanced heart failure patients awaiting heart transplantation
21. Suivi éducatif à domicile dans l’insuffisance cardiaque par télémédecine. Étude multicentrique bas normande randomisée. Résultats préliminaires
22. Infection à CMV réfractaire et résistant en transplantation d'organe solide : une étude de cohorte rétrospective comparative, Quelle place pour le letermovir ?
23. Waitlist Outcomes in Candidates with Hypertrophic or Restrictive Cardiomyopathy and Congenital Heart Disease After Implementation of the New French Heart Allocation System
24. Factors Associated With Genotypic Resistance and Outcome Among Solid Organ Transplant Recipients With Refractory Cytomegalovirus Infection.
25. (787) - Prognostic Risk Factors After Antibody Mediated Rejection in Heart Transplantation
26. (774) - Impact of Early Graft Dysfunction on Conditional 1-Year Post-Transplant Survival: A French National Cohort Study
27. (126) - Fifteen Years Experience of Veno-Arterial Extracorporeal Membrane Oxygenation for Primary Graft Dysfunction After Heart Transplantation
28. (12) - Short-Term Immuno-Molecular Landscape in 10-Gene Edited Pig-to-Human Heart Xenografts
29. Development and validation of an individual predictive model for risk of biopsy-proven antibody-mediated rejection after heart transplantation
30. Correlation between microvascular inflammation in endomyocardial biopsies and rejection transcripts, donor-specific antibodies and graft dysfunction in antibody-mediated rejection
31. Development and validation of specific post-transplant risk scores according to the circulatory support status at transplant: A UNOS cohort analysis
32. P610Akt-mediated cardioprotective effects of aldosterone in type 2 diabetic mice
33. P598Deleterious effects of cardiac aldosterone and exercise in type 2 diabetic mice
34. Development and Validation of an Individual Predictive Model for Risk of Biopsy-Proven Antibody-Mediated Rejection after Heart Transplantation
35. Development and Validation of Specific Post-Transplant Risk Scores According to the Circulatory Support Status at Transplant: A UNOS Database Analysis
36. (748) Development and Validation of Specific Post-Transplant Risk Scores According to the Transplant Era: A Unos Cohort Analysis
37. (518) Impact of the 2018 French Allocation Scheme on the Profile of Heart Transplantation Candidates and Recipients: Insights from a High-Volume Center
38. (49) Heart Transplant Allocation Policy Using an Algorithm: Putting the Pieces Together
39. Incidence of sudden cardiac death after heart transplantation
40. Statistical performance of sixteen post-transplant risk scores in a contemporary cohort of 9396 heart transplant recipients
41. Determinants of sudden cardiac death after heart transplantation
42. Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation and association with mortality: a population-based study
43. Identification of trajectories of cardiac allograft vasculopathy after heart transplantation: a nationwide comparison
44. Determinants of trajectories of cardiac allograft vasculopathy after heart transplantation: a population based study
45. Incidence of sudden cardiac death after heart transplantation
46. Determinants of sudden cardiac death after heart transplantation
47. Artérite des petites artères rénales au cours des vascularites à ANCA : une forme méconnue au pronostic sombre
48. Cytomegalovirus Infections are Frequent after Heart Transplantation but Do Not Increase the Risk of Biopsy-Proven Allograft Rejection in the Modern Era
49. Incidence and risk factors for biopsy-proven heart allograft rejection during the first-year post heart transplantation
50. A Direct Heart-Transplantation Strategy in Selected Patients on Extra-Corporeal Membrane Oxygenation Achieved Favorable Post-Transplant Outcomes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.